Teva, a provider of generic pharmaceutical drugs, has introduced Rivastigmine capsules for generic prescription. Rivastigmine is generic equivalent to Novartis' Exelon capsules. Rivastigmine is indicated for use in the symptomatic ...
Tags: Teva, rivastigmine, Novartis'Exelon capsules
US-based Rehrig Pacific, a manufacturer of reusable transport packaging systems, and Intelleflex, a provider of on-demand data visibility for cold chain asset management, have announced a strategic solution partnership, in a bid to improve ...
Rehrig Pacific and Intelleflex have formed a strategic solution partnership to improve the quality and traceability of temperature-sensitive products in the cold supply chain. The partnership is expected to develop reusable transport ...
Tags: company cooperation, transport packaging solutions, management solution
UCB has launched Neupro (Rotigotine Transdermal System) in US pharmacies for the treatment of Parkinson's disease (PD) and Restless Legs Syndrome (RLS). Neupro received the US Food and Drug Administration approval on 3 April 2012. UCB ...
Tags: Neupro, Rotigotine Transdermal System, PD, RLS
UK-based handSteady launched a cup to make drinking easy for disabled and elderly which was designed by inventor Chris Peacock. Chris Peacock designed handSteady after his close family member was diagnosed with Parkinson's disease and was ...
Tags: Cup for Disabled and Elderly, drinking easy, quality of life
Forest Laboratories and Adamas Pharmaceuticals have collaborated for the development of a fixed dosed combination (FDC) of Namenda XR and donepezil HCl for Alzheimer's dementia in the US. The company expects to launch the FDC that will be ...
MedGenesis Therapeutix, a biotechnology company, has received a grant from the Deutsche Parkinson Vereinigung e.V. for the Phase II development of glial cell line derived neurotrophic factor (GDNF). MedGenesis chairman and CEO Dr. Erich ...
Tags: Advance Gdnf, MedGenesis Therapeutix, Parkinson's disease
Titan Pharmaceuticals has completed preclinical study of its long-term,non-fluctuating dopamine agonist,as a treatment for Parkinson's disease. The preclinical study included in-vitro characterization of implant formulations of two ...
Tags: Titan Pharmaceuticals, Parkinson's disease, ProNeura drug
Brainsway has started the multicenter clinical trial of its Deep TMS device, designed to treat various neurological and psychopathological disorders. Noninvasive Deep TMS device has also the potential to treat schizophrenia, obesity, ...
Tags: Brainsway, Deep TMS device, Parkinson's disease, Alzheimer's disease
Name:Scott Morrison Age:48 Time with company:10 years;Morrison was the first employee hired Education:Honors degree from Simon Fraser University in Computer Science,with a minor in English literature and a concentration in mathematics ...
Tags: Scott Morrison, Layer 7 Technologies, security and management products
Epiwafer foundry and substrate maker IQE plc of Cardiff,Wales,UK says that it has enhanced wafer inspection capabilities at its Cardiff facility by acquiring a new automated wafer inspection tool supplied by Nanotronics Imaging LLC of ...
Tags: IQE, Nanotronics, Inspection, Microscopy
InSightec Image Guided Treatment, a subsidiary of Elbit Medical Technologies, has signed a memorandum of understanding (MOU) with GE Healthcare. Under the MOU, GE Healthcare will invest $27.5m in Insightec, reports globes.co.il. ...
Epiwafer foundry and substrate maker IQE plc of Cardiff, Wales, UK has appointed Eliot Parkinson as general manager of its III-V facility in Cardiff. Parkinson takes over from Adrian Meldrum, who has been acting as interim general ...
Tags: facility, director, manufacturing
Newron Pharmaceuticals has signed a strategic collaboration and licence agreement with Zambon Company for Safinamide in the EU and US. As per the agreement, Zambon will initially invest €20m into Newron, covering the completion ...
Tags: collaboration, pharmaceutical product, clinical development, Safinamide